Published :
Tables : 61
Figures : 52
Category : Healthcare
No. of Pages : 235
Report Code : HC-U3328
Phytopathological Disease Diagnostics Market is estimated to register a CAGR of over 4% during the forecast period 2020 to 2027. Increase in the prevalence of phtopathological diseases, growing developments in the diagnostic technologies for treating these diseases are some factors driving the phytopathological disease diagnostics market growth. The plant pathology sector has made some substantial developments by elucidating the principles of disease epidemics and this has resulted in improvements in the empirical understanding of disease dynamics. Furthermore, it has improved the accuracy of a disease outbreak or the necessity for real-time disease control and strategic solutions to disease-related issues. Molecular diagnostic methods based on PCR are being increasingly used for guiding the diagnosis of phytopathological diseases. Furthermore, rising prevalence of plant-related diseases along with the risen availability of genomic and genetic information, which has resulted in the rapid PCR incorporation in clinical laboratories. The high sensitivity, specificity and low requirement of samples has made molecular assays a regularised method for detecting pathogens during a disease outbreak. Such phytopathological disease diagnostics market trends shall propel the market growth. Market Segmentation: By Product • Kits • Accessories • Other Consumables By Test • PCR-Based Assays • Isothermal Amplification Assays • Serological Tests • Others By End User • Academic and Research Institutes • Food Processing Laboratories • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into product, test, end user and region. The product segment is categorised into kits, accessories and other consumables. The test segment is diversified into PCR-based assays, isothermal amplification assays, serological tests and others. The end user segment is classified into academic and research institutes, food processing laboratories and others. Regional Analysis: The North America region is predicted to dominate the market during the forecast period owing to rising research and development activities, a strong presence of key market players, systematic diagnostic laboratories and the high adoption of advanced assay technologies. Furthermore, there has been significant developments made in plant genomic and genetic engineering research in biotech industries present in the region. Competitive Landscape: Some of the major market players are Abingdon Health, Agdia Inc., BIOREBA AG, Creative Diagnostics, LOEWE Biochemica GmBH, Norgen Biotek Corp., Qualiplante SAS, TwistDx Limited. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global phytopathological disease diagnostics market by product, by test, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increase in the prevalence of phtopathological diseases, growing developments in the diagnostic technologies for treating these diseases are some factors driving the phytopathological disease diagnostics market growth. The plant pathology sector has made some substantial developments by elucidating the principles of disease epidemics and this has resulted in improvements in the empirical understanding of disease dynamics. Furthermore, it has improved the accuracy of a disease outbreak or the necessity for real-time disease control and strategic solutions to disease-related issues. Molecular diagnostic methods based on PCR are being increasingly used for guiding the diagnosis of phytopathological diseases. Furthermore, rising prevalence of plant-related diseases along with the risen availability of genomic and genetic information, which has resulted in the rapid PCR incorporation in clinical laboratories. The high sensitivity, specificity and low requirement of samples has made molecular assays a regularised method for detecting pathogens during a disease outbreak. Such phytopathological disease diagnostics market trends shall propel the market growth.
Market Segmentation:
By Product • Kits • Accessories • Other Consumables By Test • PCR-Based Assays • Isothermal Amplification Assays • Serological Tests • Others By End User • Academic and Research Institutes • Food Processing Laboratories • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into product, test, end user and region. The product segment is categorised into kits, accessories and other consumables. The test segment is diversified into PCR-based assays, isothermal amplification assays, serological tests and others. The end user segment is classified into academic and research institutes, food processing laboratories and others.
Regional Analysis:
The North America region is predicted to dominate the market during the forecast period owing to rising research and development activities, a strong presence of key market players, systematic diagnostic laboratories and the high adoption of advanced assay technologies. Furthermore, there has been significant developments made in plant genomic and genetic engineering research in biotech industries present in the region.
Competitive Landscape:
Some of the major market players are Abingdon Health, Agdia Inc., BIOREBA AG, Creative Diagnostics, LOEWE Biochemica GmBH, Norgen Biotek Corp., Qualiplante SAS, TwistDx Limited.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global phytopathological disease diagnostics market by product, by test, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Phytopathological Disease Diagnostics Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Kits 7.2 Accessories 7.3 Other Consumables 8. Phytopathological Disease Diagnostics Market, By Test Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 PCR-Based Assays 8.2 Isothermal Amplification Assays 8.3 Serological Tests 8.4 Others 9. Phytopathological Disease Diagnostics Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Academic and Research Institutes 9.2 Food Processing Laboratories 9.3 Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4. Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 UAE 14.2.2 South Africa 14.2.3 Egypt 14.2.4 Saudi Arabia 14.2.5 Rest of MEA 14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 Abingdon Health 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Agdia Inc. 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 BIOREBA AG 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 Creative Diagnostics 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 LOEWE Biochemica GmBH 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Norgen Biotek Corp. 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 Qualiplante SAS 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8 TwistDx Limited 15.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics